The inactivation of staphylococcus bacteriophage by an artificially produced anti-phagic serum was first reported by Gratia and Jaumain", who also found that normal rabbit serum inhibits staphy phage,-in some instances to a titer. as high as 1: 500. More recently it has been observed (Rosenthal29, Raiga24 25, Biglieri and Fischer4, Applebaum and MacNeal2, Colvin8, and Evans"0) that normal human serum, as well as pus, possesses the power to inhibit staphylococcus and streptococcus bacteriophages. Red blood cells do not influence the action of either staphylococcus or coli bacteriophage.
The inactivation of staphylococcus bacteriophage by an artificially produced anti-phagic serum was first reported by Gratia and Jaumain", who also found that normal rabbit serum inhibits staphy phage,-in some instances to a titer. as high as 1: 500. More recently it has been observed (Rosenthal29, Raiga24 25, Biglieri and Fischer4, Applebaum and MacNeal2, Colvin8, and Evans"0) that normal human serum, as well as pus, possesses the power to inhibit staphylococcus and streptococcus bacteriophages. Red blood cells do not influence the action of either staphylococcus or coli bacteriophage.
The early studies of d'Herelle'8 led him to state that normal serum has no effect on bacteriophage. At that time he was chiefly concerned with bacteriophages active against members of the enteric group-chiefly coli and dysentery. Since it is rare to find a human serum which inhibits coli bacteriophage, d'Herelle's statement concerning the effect of serum on these phages still holds true. However, anti-coli bacteriophagic serum may be artificially produced following the technic of Bordet and Ciuca5.
The term anti-phage, descriptive of the phage-inhibiting principle in serum, was proposed by Sonnenschein". He observed that normal human serum contains no anti-phage for paratyphoid B bacteriophage, but that the serum of an individual infected with B. paratyphosus B and the serum of a carrier of this organism were inhibitory to the bacteriophage. He, therefore, proposed the use of specific bacteriophage and anti-phage for diagnostic serological reactions. Katsu'9 attempted to utilize this method for the diagnosis of Flexner dysentery, but his results were too inconsistent to be of value.
Raiga2" has studied this test in connection with therapeutic failure in cases of staphylococcus infection treated with bacteriophage. In those individuals who failed to respond to phage given locally or intravenously, he found in their serum anti-staphylococcus phage antibody, and in addition a considerable amount of anti-streptococcus phagic principle. He deduces that it is the presence of the latter that nullifies the action of the bacteriophage. Both of these prin-* From the Department of Immunology, Yale University School of Medicine. ciples in the serum may be markedly reduced and even wiped out by autohemotherapy. Since this anti-bacteriophagic substance is specific, as has been shown by d'Herelle and Eliava"5, Bordet and Ciuca5, Burnet6, Asheshov3, Schlesinger30, Kendrick20, and others, it is not clear why streptococcus bacteriophage antibody should interfere with a staphylococcus bacteriophage.
The union between bacteriophage and anti-phage is a very rapid one, most of the phage being neutralized within 30 minutes when the test is carried out at 370 C. (Kenidrick20, Andrewes and Elford', and d'Herelle and Rakieten"6). Neutralization, can take place at icebox temperature (3 to 5°C.), but a considerable period of time must elapse for the reaction to take place. Gratia and Mutsaars"2 and Mutsaars" assume that the serum influences the bacteriophage indirectly by protecting the bacteria with a colloidal coating of serum, thereby preventing the phage from becoming adsorbed to the bacterial cell. Andrewes and Elford', however, postulate the presence of a serum receptor on the bacteriophage molecule which, independent of a secpnd receptor-that for the bacterial cell-combines with a specific anti-phagic serum and becomes neutralized. The union between the bacteriophage and the serum results in a blocking of the bacterial receptor, and because of this there is failure to lyse the bacterial cell.
It has been observed in this laboratory for the past several years that whole blood exerts an inhibitory effect upon staphylococcus and streptococcus phages. Recognition of this fact shows that it is practically useless to attempt isolation or production of bacteriophages in a medium containing whole blood or serum. When serum is necessary for the development of the bacteria, it should be tested for the presence of anti-phage; only samples having the anti-phagic property in small or minimal quantities being utilized.
These observations suggest that the presence of an inhibitor to staphylococcus phage may be a matter of some importance, and it was considered desirable to ascertain how frequently such an antisubstance is to be encountered in sera.
Mater?als and Methods A one per cent Savita broth was employed for the cultivation of the bacteria as well as for bacteriophage production. Two strains of hemolytic Staphylococcus aureus (Sta. Pg, and Sta. Vnt) served as the phage-suscep-tible cultures. Stock cultures were maintained on Savita agar slants and kept in the ice-box. For the purposes of the experiments 12-to 15 -hour broth cultures were used.
Four races of polyvalent staphylococcus phage were tested for their ability to withstand the neutralizing effect of human sera. Bacteriophage "PG," which had been maintained for some three years with a single culture of staphylococcus, "Pg," is a phage which acts particularly well in the presence of hemolytic staphylococci. Diluted 10' to 10' it brings about complete lysis of cultures "Pg" and "Vnt" in 6 hours at 350 C. Secondary cultures appear after incubation for 48 hours. Bacteriophage "1 OM9" has been developed in this laboratory, several strains of staphylococci, including cultures "Pg" and "Vnt," being used in its maintenance. This phage has also been made what we have chosen to call "yeast-fast." Diluted 10-10 it lyses both of the test cultures within a period of from 5 to 6 hours. Secondary culture rarely appears. Bacteriophage "Mich," obtained from Larkum, also attacks both of the test cultures. Bacteriophage "AP" is a polyvalent bacteriophage which has been adapted to an artificially produced anti-phagic serum.
The sera to be tested were obtained by venepuncture of patients in the New Haven Hospital and Dispensary, from members of the nursing and clinical staffs, and from medical students. The sera were not inactivated by heating and were usually used within 15 hours after collection.
The anti-phage test employed was essentially the "direct anti-phage test" of Rosenthal29, the quantities of serum, bacteriophage, and bacteria being those indicated below. Dilutions of serum were made with physiological saline and to each 0.5 cc. of diluted serum an equal quantity of bacteriophage was added. The final concentrations of serum were 1: 2, 1: 4, 1: 8, 1: 16, and 1: 32. Two additional tubes were added to the series, one containing 0.5 cc. of bacteriophage and an equal amount of saline, the other containing at least 0.1 cc. of serum in 10 cc. of broth. These mixtures were incubated for 3 hours at 350 C., after which two drops from each of the first six tubes of the series were transferred to tubes of Savita broth. To each of the broth tubes thus inoculated, and to an additional tube of broth, 0.1 cc. of a 15-hour broth culture of staphylococcus was added. Further incubation was at 350 C. for 18 hours.
A test was considered satisfactory only when tube 6 resulted in complete clearing (4+ lysis) and when the control tube containing only serum and broth showed no bacterial growth. The amount of turbidity present in tube 8 served as the standard; all tubes containing serum-phage-culture mixture were read in terms of this tube. Those as cloudy as tube 8 indicated that the serum had neutralized completely the lytic activity of the phage. Those tubes that remained as clear as tube 6 indicated that no inhibition of the phage by the serum had occurred. Readings were made after shaking the tubes, in order to avoid error due to bacterial sedimentation.
The serums of several patients were retested at varying intervals in order to ascertain whether the anti-phagic substance was stable or would disappear on standing.
Experimental
All of the sera were tested for their anti-phagic action against bacteriophage "PG," the susceptible bacterial strain being staphylococcus "Pg." The results: It is apparent from this table that anti-phage was demonstrated in 199 of 200 individuals when the phage utilized was "PG" and the susceptible culture was "Pg." Of these individuals, 84 gave no history of ever having had a staphylococcus infection, but did have in their serum anti-phage in a dilution of at least 1: 8. The titer of this antibody corresponds dosely with that which one can demonstrate against a virus disease such as poliomyelitis, and from individuals who have a negative history with regard to that disease.
Those cases listed as giving a positive history were those having had boils, furunculosis, or infected wounds in the past, and those showing evidence of staphylococcus infection at the time the serum was obtained. In this latter group were people with osteomyelitis, chronic cases of furunculosis, boils, carbuncles, paronychia, and infections following abrasions and trauma. The concentration of antiphage in the serum of these cases was practically the same as in the non-infected group, both with regard to the titer and to the number of individuals. Thus, it appears that anti-phage against staphylo-coccus bacteriophage is common in human sera, and that there is no direct relationship between the concentration of this substance and the presence of infection with the staphylococcus.
However, if another strain of staphylococcus (e.g., "Vnt") is employed in the test, using the same phage, a distinct difference with regard to the concentration of the anti-phage is observed. It may be stated again that bacteriophage "PG" lyses equally well both strains of staphylococcus-"Pg" and "Vnt"-in the same period of time at the same dilution (10) . Hence, the difference in the results can not be attributed to a difference in number of corpuscles active against "Vnt" as compared with those effective with "Pg."
The results obtained with 32 of these sera tested with bacteriophage "PG" and staphylococcus "Vnt" are recorded in Table II . It may be observed that anti-phage was demonstrated in 28 of these cases when the same bacteriophage was used, but with a different bacterial host. It is significant that the highest titer reached by any of the sera was only 1: 8, whereas in using staphylococcus "Pg" as the host over 50 per cent of the sera had titers of at least 1:16.
In order to bring out the importance of the choice of the race of bacteriophage as well as of the susceptible strain employed in carrying out this test, a number of sera were tested for the presence of phage-inhibiting substance against phage "10M9," using both bacterial strains as hosts. This phage contained more active corpusdes for both of these strains, since it was still fully effective when diluted to 1 010. The results are summarized. These results show that when staphylococcus "Pg" is used antiphage may be demonstrated more frequently in cases that have had a history of infection and that when staphylococcus "Vnt" is used a considerable number of sera have no demonstrable anti-phage regardless of the history of the cases. Again, it may be observed that when strain "Pg" is employed the majority of sera have anti-phage in a titer of 1: 8 and 1: 16, but with the employment of staphylococcus "Vnt" none of the sera has inhibitory substance in a concentration above 1 :8.
Several of the sera were tested against four races of bacteriophage, using one or both strains of bacteria, this procedure being followed because it appeared that the so-called anti-phage was not a real substance in the serum, but simply a measure of failure of the phage to act in the presence of serum. Phages "PG" and "Mich" may be termed stock polyvalent phages. Phage "1 OM9" is one that had been made yeast-fast, and phage "AP" had been adapted to an artificially produced anti-phagic rabbit serum. Table IV illustrates some of the results obtained when phage "PG" was used with strain "Pg," and the other three phages with strain "Vnt." It is evident that in the sera of cases 100 and 101, which are examples of several tested under similar conditions, there is present anti-phage active against phage "PG" when the host organism is strain "Pg." A different idea concerning the concentration of antiphage in the same serum may be obtained by using a different bacteriophage with an organism that is just as susceptible to it as is strain "Pg." The results obtained with bacteriophage "AP" are interesting in that every time that this phage was employed, regardless of whether the host was "Pg" or "Vnt," there was very little evidence of any anti-phage in the serum tested. In the adaptation of this phage to an anti-phagic serum staphylococcus "Vnt" was used as the host strain.
Many of the sera, after testing, were stored, without preservative, in the ice-box for periods of from 3 weeks to 4 months, when they were retested for anti-phagic action. There was no indication that the antibody, so-called, diminished on standing, for the results with the same phage and the same bacterial strain were the same as when the sera were first tested. The anti-phagic antibody is as heat stable as are agglutinins; boiling for three minutes destroys it (Kendrick20).
The studies of d'Herelle and Eliava"5 with coli bacteriophage and an artificially produced anti-phagic serum led to the conclusion that the serum caused but a temporary inhibition of bacteriophage, and that with prolonged incubation lysis of the bacteria would result. Gratia and Jaumain11 reported that the union between phage and serum was irreversible, and that once it occurred no lysis by the phage took place. We examined 9 different sera using phage "PG" and staphylococcus "Pg" for evidence on this point. Even after a week's incubation there was no significant clearing in any of the dilutions of serum in which inhibition of phage had occurred. While this would appear to argue against release of the phage, it can be demonstrated by means of a plaque method that there are in those tubes that macroscopically show little evidence of lysis, hundreds of active corpuscles. It may be that the reason for the failure to lyse during a prolonged period of incubation is due to the refractory state of the bacterial cells. It must be borne in mind that lysis occurs during the growth phase of the organisms. Even if the neutralization between phage and serum had been disrupted the bacterial cells themselves would be in a highly refractory state toward lysis by the freed phage.
The presence of anti-phage seems to be in no way determined by sex; of the 200 sera tested 113 were from males. One hundred of the 113 samples contained anti-phage toward phage "PG" in a dilution of at least 1: 8 (42 sera, 1: 8; 44 sera, 1: 16; 26 sera, 1:32). All of the 87 samples obtained from females contained anti-phage (32 sera, 1: 8; 36 sera, 1:16; 12 sera, 1:32).
The recent work of Jungeblut"8 regarding age and antibody production, particularly antibodies to poliomyelitis virus, suggested a grouping of the cases here studied on the age basis. Table V gives the results when the phage used was "PG." Obviously, the disproportion in the number of individuals in the various age groups is so great that definite conclusions are unwarranted, but it would appear that with increase in age up to 40 years there seems to be an increase in the titer of the antibody present.
Anti-phagic substance against staphylococcus bacteriophage is also commonly found in the serum of rabbits. Tests of the sera of 30 rabbits of various ages showed that in 26 anti-phage active against phage "1 OM9", using staphylococcus "Vnt," was found. The concentration of anti-phage varied from 1: 2 to as high as 1: 512. Obviously, if one is interested in determining the length of time that staphylococcus phage may be demonstrated in the blood stream of rabbits after intravenous injection, the presence of this antibody should be considered. If it is present in demonstrable amounts the rapid disappearance of an injected phage is readily understood.
The phage-inhibiting agent in serum is not removed by filtration through a Chamberland L5 candle.
The artificial production of an anti-phagic serum in rabbits necessarily entails the development of an anti-bacterial serum, since the filtrate used as antigen contains dissolved bacterial protein as well as bacteriophage. It was of interest to consider naturally occurring anti-phage from this point of view. Serum  number  22  24  26  27  28  29  30  33  39  40  58  61  62  63  69  71  73  74  75  76  97  98 These results lead to the conclusion that there is little or no relation between the occurrence of anti-phage in human serum and the presence of agglutinins for staphylococcus "Pg." There is, however, an apparent relation between the presence of agglutinins and a positive history of staphylococcus infection. We have produced rabbit anti-phagic sera, which diluted as high as 1: 3200 inhibited the bacteriophage, although they contained agglutinins to a titer of only 1: 400 for the susceptible strain of bacteria used in the production of the phage.
Just as it is possible to adapt a staphylococcus bacteriophage to an anti-phagic serum, so also can phage be adapted to act in the presence of yeast. Such a phage is also able to maintain itself and multiply in higher concentrations of human sera, pus, and egg albumin than are stock phages.
When staphylococcus bacteriophage is placed in a medium, free of sugar, in which yeast cells will develop there is a marked reduction in the corpuscular count of the bacteriophage, although the yeast cells themselves are not affected. If, then, a portion of the filtrate from this mixture is allowed to develop at the expense of a susceptible strain of bacteria, and this phage is again placed in contact with growing yeast cells the reduction in corpuscular count is less than in the initial contact. By repeating this procedure it is possible to produce a phage whose corpuscular count and polyvalency remain unaffected by contact with yeast. Coincident with this changed behavior toward yeast there develops an increased ability of the "yeast-fast" phage to act in body fluids, such as blood, serum, pus, and urine. The strain of yeast seems to be unimportant, at least, in tests made with four varieties-a Moselle wine yeast, a top yeast, a bottom yeast, and a bread yeast-this is true. The phage that becomes "fast" to one is also "fast" to the others.
Some races of staphy phage acquire this yeast-fastness after only two contacts, others require as many as seven. Yeast does not appear to exert a comparable effect on either coli or dysentery phages.
These experiments with yeast, conducted in 1932 and 1933, offered no explanation for the peculiar adsorptive behavior of staphy phage as contrasted with coli or dysentery phages. That the past environmental conditions of the phages might be significant correlates well with the recognized difficulty in isolating staphy phage from materials which readily yield phages of other types. However, the recent work of Levine and Frisch22 suggests that the adsorp-tion of staphy phage by yeast may be due to the presence in yeast of staphylococcus substance. If this is true, it may well be that staphylococcus phage can be adapted to withstand the adsorbing power of this substance, for the procedure herein outlined is, in effect, a selection of only the resistant corpuscles. But whatever the explanation may be, the fact remains that the yeast-adapted phage is more resistant to serum than are stock phages. Such a yeast-fast phage administered intravenously to individuals with a staphylococcus septicemia (500 colonies per cc.) has been recovered from the blood stream, retaining its activity in concentrations of the serum which were inhibitory to stock phages. The two patients to whom the phage was given died with miliary abscesses studding the liver, spleen, and kidney, although the ante-mortem blood cultures were sterile.
Biglieri and Fischer4 have reported the occurrence of anti-phage against coli bacteriophage in human serum. Of the 62 human sera which we have tested, inhibition of coli phage was noted in only 6 cases, but where present it disappeared when the sera were diluted above 1: 2. We have never observed inhibition by either rabbit or horse serums. The fact that anti-coli phagic substance is so rare in serum may explain the persistence of injected phage in the blood stream. We have recently demonstrated its presenee in the blood stream of an individual 36 hours after it was given intravenously.
Discussion
While the presence of anti-phage, especially against staphylococcus bacteriophage, has been demonstrated by several investigators, Raiga is the chief proponent of the idea that this antibody seriously interferes with intravenous staphylococcus bacteriophage therapy.
The theoretical basis for such an interpretation is obvious.
The experiments of Kreuger et al."1 bearing upon the persistence of staphylococcus bacteriophage in the blood following intravenous injection are difficult to interpret, since hi's animals (rabbits) may or may not have had this antibody in their serum. Our studies incline us to a belief that it is very commonly encountered in rabbit serum. One can understand the reason for the rapid disappearance of staphylococcus bacteriophage in such animals, since the neutralization of phage by serum takes place within a few minutes. Although it may be possible for the remaining unneutralized corpuscles to bring about a change in the bacteria in the blood stream (d'Herelle and Beecroft'4, d'Herelle and Rakieten"7) one must not forget that the bacteria may also be multiplying and their increase may be of such magnitude that bacteriophagy is improbable.
Staphylococcus anti-phage appears, under certain conditions, to' be extremely common in human sera. These conditions, namely, the race of bacteriophage employed together with the strain of bacteria used as the susceptible host, may yield results that can hardly be regarded as valid, since the same sera tested with another bacteriophage gives a wholly different result.
The anti-phagic action of serum may perhaps be interpreted in another way,-as the lack of some distinctive property in the particular phage used for determination.
It is certain that the presence of anti-phage for bacteriophage "PG" does not correlate with infection, either past or present, and while anti-phage is more frequently found in the age groups most likely to show antibodies toward viruses, it is probable that with phage "PG" inhibition by serum is not related to any particular age groups.
The facts now available suggest that there is little or no naturally occurring anti-staphylococcus bacteriophagic substance, as such, in human serum, but that the behavior which is termed "anti-phagic" is really due to the disability of the particular phage to bring about lysis in serum. It is unusual to isolate staphy phages from stool, perhaps because of the fact that they are absorbed by many nonspecific agents. Most of the staphylococcus phages that are used either in investigative study or for therapeutic purposes are, in the main, old laboratory races which, although they may be able to produce complete lysis in a simple broth medium, lose this power in the presence of serum. A phage which has been adapted to an antiphagic serum or has been made "yeast-fast" gains the ability to lyse bacteria in concentrations of serum that are definitely inhibitory to stock phages. Furthermore,. a phage that has been recovered from the blood stream is not rendered inert by the presence of serum. Once the phage has acquired this characteristic it retains it, without the necessity of continued contact with yeast or serum.
Although anti-phagic activity toward phage "PG" is exhibited by almost all sera, there does not seem to be any relation between this property and agglutinins for the "Pg" strain of staphylococcus.
Conclusions
Anti-staphylococcus bacteriophagic substance was demonstrated in 199 of 200 human sera tested.
The presence of naturally occurring anti-staphy phagic antibody in human sera is dependent upon (a) the race of staphylococcus bacteriophage employed and (b) the strain of susceptible staphylococcus used.
Rabbit serum frequently contains inhibiting substance toward many races of staphylococcus bacteriophage.
There does not appear to be any relationship between the presence of naturally occurring anti-staphylococcus bacteriophage antibody and a history of infection with staphylococcus, nor is there any relation between naturally occurring anti-phagic antibody and the presence of agglutinins for the staphylococcus.
The phage-inhibiting substance is heat stable at 75°C. and passes through a Chamberland L5 candle.
At ice-box temperature it remains unchanged in concentration for a period of at least three months.
Staphylococcus bacteriophages adapted to an artificially produced anti-phagic serum, or adapted to withstand the destructive action of yeast cells are only very slightly influenced, if at all, by the same concentrations of human sera that inhibit stock -staphylococcus bacteriophages.
The impression gained from this investigation is that there is no naturally occurring anti-staphylococcus bacteriophagic antibody as such, and that what is commonly so termed is in reality merely a measure of the inability of the phage to produce lysis in particular concentrations of serum.
Inhibiting substances toward coli bacteriophages in human or animal sera, if present, are encountered very infrequently.
